compounded glp‑1 cost
Prescription Weight Loss Fails: FDA Stops Compounding
The FDA’s new rule bars pharmacies from compounding semaglutide, tirzepatide and liraglutide, eliminating the roughly 30% cost savings patients once enjoyed. In 2024, 58% of GLP-1 users reported expected cost hikes of $150 or more after the FDA restriction, reshaping how budget-conscious patients access weight-loss therapy. Medical Disclaimer: This